Moreover, MTHFD2 sustains cellular UDP-GlcNAc levels to increase c-Myc O-GlcNAcylation, which enhances PD-L1 transcription, contributing to tumor resistance against T-cell cytotoxicity [130]. Here, MYC is linked to neoplasm.